Pricing Human Papillomavirus Vaccines: Lessons from Italy

By Garattini Livio   >   Curto Alessandro  

PharmacoEconomics, Vol. 30, Iss. 3, 2012-03 ,pp. : 213-217

Adis International

Access to resources Recommend Favorite

Emerging human papillomavirus vaccines

By Christensen Neil D  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 5-19

Informa Healthcare

Access to resources Recommend Favorite

Emerging human papillomavirus vaccines

By Ma Barbara  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 469-492

Informa Healthcare

Access to resources Recommend Favorite

Beyond Vaccines for Cervical Cancer: Topical Therapies for Human Papillomavirus Diseases1 1 The full text of this article was published in BioDrugs 2006;20(4):209-218. The original article was written by Katie Green and Kevin Gaston from the Department of Biochemistry, School of Medical Sciences, University of Bristol, UK.

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 9, 2006-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Recent developments in human papillomavirus vaccines

By Stern Peter L  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 959-971

Informa Healthcare

Access to resources Recommend Favorite